Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Horn DB … Lee CJ Journal: The Lancet Published: 2026-06-06 DOI: https://doi.org/10.1016/S0140-6736(26)00656-2